Rate of Depression Growing During COVID-19, BrainsWay CEO Discusses Importance and Effectiveness of Deep TMS Treatment
![](https://static.wixstatic.com/media/a8e651_6109bbeafc22433cb462f93ec040130e~mv2.jpg/v1/fill/w_500,h_500,al_c,q_80,enc_auto/a8e651_6109bbeafc22433cb462f93ec040130e~mv2.jpg)
BrainsWay CEO Christopher von Jako outlines the importance on how informing the public on Deep TMS as an effective non-invasive treatment option for depression and OCD is more critical than ever given the mental health crisis resulting from the COVID-19 pandemic.
Комментарии